Fidelity Investments’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148M | Sell |
|
|||||
|
2025
Q1 | $177M | Buy |
|
|||||
|
2024
Q4 | $183M | Buy |
|
|||||
|
2024
Q3 | $209M | Sell |
|
|||||
|
2024
Q2 | $158M | Sell |
|
|||||
|
2024
Q1 | $176M | Sell |
|
|||||
|
2023
Q4 | $170M | Sell |
|
|||||
|
2023
Q3 | $179M | Sell |
|
|||||
|
2023
Q2 | $192M | Sell |
|
|||||
|
2023
Q1 | $183M | Buy |
|
|||||
|
2022
Q4 | $308M | Sell |
|
|||||
|
2022
Q3 | $249M | Buy |
|
|||||
|
2022
Q2 | $265M | Buy |
|
|||||
|
2022
Q1 | $238M | Buy |
|
|||||
|
2021
Q4 | $179M | Buy |
|
|||||
|
2021
Q3 | $158M | Sell |
|
|||||
|
2021
Q2 | $139M | Sell |
|
|||||
|
2021
Q1 | $240M | Sell |
|
|||||
|
2020
Q4 | $274M | Sell |
|
|||||
|
2020
Q3 | $280M | Buy |
|